Combat pneumococcal infections: adhesins as candidates for protein-based vaccine development

Area of Science:

• Microbiology
• Immunology
• Vaccinology

Background:

• Streptococcus pneumoniae (pneumococcus) colonizes the upper respiratory tract but can cause severe invasive diseases like pneumonia, septicaemia, and meningitis.
• Current treatments rely on antibiotics and polysaccharide vaccines, but rising antibiotic resistance and vaccine limitations necessitate new strategies.
• Pneumococcal surface proteins are crucial for bacterial adherence, colonization, host barrier transmigration, and immune evasion, making them potential vaccine targets.

Purpose of the Study:

• To review the conservation, distribution, and pathogenic role of pneumococcal adhesins in colonization and invasive diseases.
• To explore the interactions between pneumococcal virulence factors, host proteins, and cellular receptors.
• To discuss the subversion of host immune responses by pneumococci and evaluate adhesins as vaccine candidates.

Main Methods:

• Literature review of recent discoveries on pneumococcal adhesins.
• Analysis of pathogenic mechanisms involving bacterial-host interactions.
• Evaluation of immunogenic potential of surface-exposed proteins.

Main Results:

• Pneumococcal adhesins play critical roles in pathogenesis, including adherence and invasion.
• These adhesins interact with host proteins and receptors, facilitating colonization and immune evasion.
• Certain conserved adhesins are promising candidates for a new generation of protein-based vaccines.

Conclusions:

• Targeting pneumococcal adhesins offers a promising strategy to overcome limitations of current vaccines and antibiotics.
• Further research into adhesin-host interactions can guide the development of effective vaccines against pneumococcal diseases.
• Protein-based vaccines targeting conserved adhesins could provide broad protection against diverse pneumococcal strains.